{"id":18878,"date":"2024-09-23T02:04:02","date_gmt":"2024-09-23T05:04:02","guid":{"rendered":"https:\/\/jppres.com\/jppres\/?p=18878"},"modified":"2024-09-23T02:04:02","modified_gmt":"2024-09-23T05:04:02","slug":"lytechinus-variegatus-peptides-and-colorectal-cancer","status":"publish","type":"post","link":"https:\/\/jppres.com\/jppres\/lytechinus-variegatus-peptides-and-colorectal-cancer\/","title":{"rendered":"Lytechinus variegatus peptides and colorectal cancer"},"content":{"rendered":"<p id=\"block-5741ffb1-4d48-49ef-bc47-a7f95de5f1e4\"><strong>J. Pharm. Pharmacogn. Res., vol. 13, no. 1, pp. 341-355, Jan-Feb 2025<\/strong>.<\/p>\r\n<!-- \/wp:post-content --><!-- wp:paragraph -->\r\n\r\nDOI: <a title=\"DOI\" href=\"https:\/\/doi.org\/10.56499\/jppres24.2085_13.1.341\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.56499\/jppres24.2085_13.1.341<\/a>\r\n\r\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\r\n<p id=\"block-f17315b8-886c-4dac-ad1f-7bcd24a2ba7e\"><strong>Original Article<\/strong><\/p>\r\n<!-- \/wp:paragraph --><!-- wp:heading {\"level\":1} -->\r\n<h1 id=\"block-26c9d67c-0a86-46c5-a39d-baed3ab66870\" class=\"wp-block-heading\">Bioinformatic investigation of <i>Lytechinus variegatus<\/i> coelomic fluid peptides as multiple oncogenic proteins inhibitors of colorectal cancer<\/h1>\r\n<!-- \/wp:heading --><!-- wp:heading -->\r\n<h2 id=\"block-af2f270d-95f2-4c97-9976-5f4b011c299c\" class=\"wp-block-heading\">[Investigaci\u00f3n bioinform\u00e1tica de p\u00e9ptidos del l\u00edquido cel\u00f3mico de <i>Lytechinus variegatus<\/i> como inhibidores de m\u00faltiples prote\u00ednas oncog\u00e9nicas del c\u00e1ncer colorrectal]<\/h2>\r\n<!-- \/wp:heading --><!-- wp:heading {\"level\":3} -->\r\n<h3 id=\"block-d9f045b2-f5c2-4ee7-9207-febdd14ef913\" class=\"wp-block-heading\">Rauza S. Rita<sup>1*<\/sup>, Kevin N. Cuandra<sup>2<\/sup>, Salsabila P. Khairani<sup>3<\/sup>, Rizky E. Putera<sup>4<\/sup>, Vella Amalia<sup>2<\/sup>, Alifya R. Shofiy<sup>5<\/sup>, Dhyani P. Wahyudi<sup>5<\/sup>, Ahmad R. Yustian<sup>2<\/sup>, Dinda P. Nabila<sup>6<\/sup>, Malya C. S. Maharani<sup>5<\/sup>, Andi A. D. Kahar<sup>7<\/sup><\/h3>\r\n<!-- \/wp:heading --><!-- wp:paragraph -->\r\n<p style=\"text-align: justify;\"><sup>1<\/sup>Department of Biochemistry, Faculty of Medicine, Universitas Andalas, Padang, Indonesia.<\/p>\r\n<p style=\"text-align: justify;\"><sup>2<\/sup>Department of Medicine, Faculty of Medicine, Universitas Andalas, Padang, Indonesia.<\/p>\r\n<p style=\"text-align: justify;\"><sup>3<\/sup>Department of Biomedical Science, Faculty of Medicine, Universitas Andalas, Padang, Indonesia.<\/p>\r\n<p style=\"text-align: justify;\"><sup>4<\/sup>Department of Medicine, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.<\/p>\r\n<p style=\"text-align: justify;\"><sup>5<\/sup>Department of Medicine, Faculty of Medicine, Universitas Pembangunan Nasional &#8220;Veteran&#8221;, Jakarta, Indonesia.<\/p>\r\n<p style=\"text-align: justify;\"><sup>6<\/sup>Department of Pharmacy, Faculty of Pharmacy, Universitas Andalas, Padang, Indonesia.<\/p>\r\n<p style=\"text-align: justify;\"><sup>7<\/sup>Departement of Physics, Faculty of Mathematics and Natural Science, Universitas Brawijaya, Malang, Indonesia.<\/p>\r\n<p style=\"text-align: justify;\">*E-mail: <a href=\"mailto:rauzasukmarita@med.unand.ac.id\">rauzasukmarita@med.unand.ac.id<\/a><\/p>\r\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\r\n<p id=\"block-2d2697d7-dd99-44e8-8909-2ed66079c9ec\"><strong>Abstract<\/strong><\/p>\r\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\r\n<p style=\"text-align: justify;\"><em>Context<\/em>: Colorectal cancer (CRC) remains a significant global health challenge despite advances in treatment modalities. The coelomic fluid of <em>Lytechinus variegatus<\/em> emerges as a rich source of bioactive peptides with the potential as a new therapeutic anticancer agent.<\/p>\r\n<p style=\"text-align: justify;\"><em>Aims<\/em>: To analyze the toxicity, allergenicity, and potential of <em>L. variegatus<\/em> coelomic fluid peptides as multitarget inhibitor agents of CRC cancer cells through an <em>in silico<\/em> study.<\/p>\r\n<p style=\"text-align: justify;\"><em>Methods<\/em>: Ten peptides from <em>L. variegatus<\/em> coelomic fluid were processed using UCSF Chimera software to model the three-dimensional structure. ToxinPred and AllerTop web servers were used to analyze the toxicity and allergenicity of peptides, respectively. The 3D structures of EGFR, AKT1, GSK3B, VEGFR2, and JAK3 were retrieved from the PDBJ database. MOE Software was used to perform molecular docking.<\/p>\r\n<p style=\"text-align: justify;\"><em>Results<\/em>: Peptide 4 binds to the ATP binding pocket of GSK3B protein with the strongest binding affinity value (-8,68 kcal\/mol). The docking results between EGFR and peptides showed that peptide 10 binds to the ATP binding pocket with the lowest binding affinity (-9.52 kcal\/mol). Peptide 2 binds to the ATP binding pocket of AKT1 with the lowest binding affinity value (-9.16 kcal\/mol). Peptide 3 has the lowest binding affinity value of the JAK3 ATP binding pocket (-8,67 kcal\/mol). Peptide 7 binds to the ATP binding pocket of VEGFR2 with the strongest binding affinity (-9,67 kcal\/mol).<\/p>\r\n<p style=\"text-align: justify;\"><em>Conclusions<\/em>: The <em>L. variegatus <\/em>peptides have the potential as multitarget anti-CRC agents by inhibiting the activity of GSK3B, EGFR, AKT1, JAK3, and VEGFR2 proteins through the ATP competitive inhibitor action based on <em>in silico<\/em> study.<\/p>\r\n<p style=\"text-align: justify;\"><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\r\n<p id=\"block-a9661cf1-284c-4433-a3fb-d15931988fba\" style=\"text-align: justify;\"><em>Keywords<\/em>: anticancer; colorectal cancer; <em>Lytechinus variegatus; <\/em>molecular docking.<\/p>\r\n<!-- \/wp:paragraph --><!-- wp:image {\"linkDestination\":\"custom\"} -->\r\n<figure class=\"wp-block-image\"><a href=\"https:\/\/jppres.com\/jppres\/pdf\/vol13\/jppres24.2085_13.1.341.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" data-src=\"https:\/\/jppres.com\/jppres\/wp-content\/uploads\/2013\/09\/jppres_pdf_free.png\" class=\"alignnone lazyload\" title=\"PDF Download\" alt=\"PDF Download\" width=\"40\" height=\"20\"><noscript><img decoding=\"async\" class=\"alignnone\" title=\"PDF Download\" src=\"https:\/\/jppres.com\/jppres\/wp-content\/uploads\/2013\/09\/jppres_pdf_free.png\" alt=\"PDF Download\" width=\"40\" height=\"20\"><\/noscript><\/a><\/figure>\r\n<!-- \/wp:image --><!-- wp:heading {\"level\":4} -->\r\n<h4 id=\"block-98722437-95d1-45d3-a5f6-d46d54bbb00e\" class=\"wp-block-heading\">Resumen<\/h4>\r\n<!-- \/wp:heading --><!-- wp:paragraph -->\r\n<p style=\"text-align: justify;\"><em>Contexto<\/em>: El c\u00e1ncer colorrectal (CCR) sigue siendo un importante desaf\u00edo para la salud mundial a pesar de los avances en las modalidades de tratamiento. El l\u00edquido cel\u00f3mico de <em>Lytechinus variegatus<\/em> surge como una rica fuente de p\u00e9ptidos bioactivos con potencial como nuevo agente terap\u00e9utico contra el c\u00e1ncer.<\/p>\r\n<p style=\"text-align: justify;\"><em>Objetivos<\/em>: Analizar la toxicidad, la alergenicidad y el potencial de los p\u00e9ptidos del l\u00edquido cel\u00f3mico de <em>L. variegatus<\/em> como agentes inhibidores multidiana de las c\u00e9lulas cancerosas del CCR a trav\u00e9s de un estudio <em>in silico<\/em>.<\/p>\r\n<p style=\"text-align: justify;\"><em>M\u00e9todos:<\/em> Se procesaron diez p\u00e9ptidos del l\u00edquido cel\u00f3mico de <em>L. variegatus<\/em> utilizando el software UCSF Chimera para modelar la estructura tridimensional. Se utilizaron los servidores web ToxinPred y AllerTop para analizar la toxicidad y la alergenicidad de los p\u00e9ptidos, respectivamente. Las estructuras 3D de EGFR, AKT1, GSK3B, VEGFR2 y JAK3 se recuperaron de la base de datos PDBJ. Se utiliz\u00f3 el software MOE para realizar el acoplamiento molecular.<\/p>\r\n<p style=\"text-align: justify;\"><em>Resultados<\/em>: El p\u00e9ptido 4 se une al bolsillo de uni\u00f3n de ATP de la prote\u00edna GSK3B con el valor de afinidad de uni\u00f3n m\u00e1s fuerte (-8,68 kcal\/mol). Los resultados del acoplamiento entre EGFR y p\u00e9ptidos mostraron que el p\u00e9ptido 10 se une al bolsillo de uni\u00f3n de ATP con la afinidad de uni\u00f3n m\u00e1s baja (-9,52 kcal\/mol). El p\u00e9ptido 2 se une al bolsillo de uni\u00f3n de ATP de AKT1 con el valor de afinidad de uni\u00f3n m\u00e1s bajo (-9,16 kcal\/mol). El p\u00e9ptido 3 tiene el valor de afinidad de uni\u00f3n m\u00e1s bajo del bolsillo de uni\u00f3n de ATP de JAK3 (-8,67 kcal\/mol). El p\u00e9ptido 7 se une al bolsillo de uni\u00f3n de ATP de VEGFR2 con la afinidad de uni\u00f3n m\u00e1s fuerte (-9,67 kcal\/mol).<\/p>\r\n<p style=\"text-align: justify;\"><em>Conclusiones<\/em>: Los p\u00e9ptidos de <em>L. variegatus<\/em> tienen potencial como agentes anti-CRC multidiana al inhibir la actividad de las prote\u00ednas GSK3B, EGFR, AKT1, JAK3 y VEGFR2 a trav\u00e9s de la acci\u00f3n inhibidora competitiva de ATP basada en un estudio <em>in silico<\/em>.<\/p>\r\n<p style=\"text-align: justify;\"><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\r\n<p id=\"block-715ba2c1-3469-40d6-b6be-af42c4d7adf9\" style=\"text-align: justify;\"><em>Palabras Clave<\/em>: acoplamiento molecular; anticancer\u00edgeno; c\u00e1ncer colorrectal; <em>Lytechinus variegatus<\/em>.<\/p>\r\n<!-- \/wp:paragraph --><!-- wp:image {\"linkDestination\":\"custom\"} -->\r\n<figure class=\"wp-block-image\"><a href=\"https:\/\/jppres.com\/jppres\/pdf\/vol13\/jppres24.2085_13.1.341.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" data-src=\"https:\/\/jppres.com\/jppres\/wp-content\/uploads\/2013\/09\/jppres_pdf_free.png\" class=\"alignnone lazyload\" title=\"PDF Download\" alt=\"PDF Download\" width=\"40\" height=\"20\"><noscript><img decoding=\"async\" class=\"alignnone\" title=\"PDF Download\" src=\"https:\/\/jppres.com\/jppres\/wp-content\/uploads\/2013\/09\/jppres_pdf_free.png\" alt=\"PDF Download\" width=\"40\" height=\"20\"><\/noscript><\/a><\/figure>\r\n&nbsp;\r\n<figure class=\"wp-block-embed is-type-rich is-provider-embed-handler wp-block-embed-embed-handler\">\r\n<div class=\"wp-block-embed__wrapper\"><a title=\"PDF\" href=\"https:\/\/jppres.com\/jppres\/pdf\/vol13\/jppres24.2085_13.1.341.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/jppres.com\/jppres\/pdf\/vol13\/jppres24.2085_13.1.341.pdf<\/a><\/div>\r\n<div><\/div>\r\n<div><\/div><\/figure>\r\n<!-- \/wp:image --><!-- wp:preformatted -->\r\n<pre class=\"wp-block-preformatted\"><strong>Citation Format:<\/strong> Rita SR, Cuandra KN, Khairani SP, Putera RE, Amalia V, Shofiy AR, Wahyudi DP, Yustian AR, Nabila DP, Maharani MCS, Kahar AAD (2025) Bioinformatic investigation of <em>Lytechinus variegatus<\/em> coelomic fluid peptides as multiple oncogenic proteins inhibitors of colorectal cancer. J Pharm Pharmacogn Res 13(1): 341\u2013355. <a href=\"https:\/\/doi.org\/10.56499\/jppres24.2085_13.1.341\">https:\/\/doi.org\/10.56499\/jppres24.2085_13.1.341<\/a><\/pre>\r\n<!-- \/wp:preformatted --><!-- wp:heading {\"level\":5} -->\r\n<h5 id=\"block-3e8fa483-61c8-4b42-b838-4b51877546f6\" class=\"wp-block-heading\">References<\/h5>\r\n<!-- \/wp:heading --><!-- wp:paragraph -->\r\n<p style=\"text-align: justify;\">Alhazzani K, Venkatesan T, Natarajan U, Algahtani M, Alaseem A, Alobid S, Rathinavel A (2022) Evaluation of antitumor effects of VEGFR-2 inhibitor F16 in a colorectal xenograft model. Biotechnol Lett 44(5\u20136): 787\u2013801. <a href=\"https:\/\/doi.org\/10.1007\/S10529-022-03243-0\">https:\/\/doi.org\/10.1007\/S10529-022-03243-0<\/a><\/p>\r\n<p style=\"text-align: justify;\">Baammi S, El Allali A, Daoud R (2023) Unleashing Nature\u2019s potential: a computational approach to discovering novel VEGFR-2 inhibitors from African natural compound using virtual screening, ADMET analysis, molecular dynamics, and MMPBSA calculations. Front Mol Biosci 10: 1227643. <a href=\"https:\/\/doi.org\/10.3389\/FMOLB.2023.1227643\">https:\/\/doi.org\/10.3389\/FMOLB.2023.1227643<\/a><\/p>\r\n<p style=\"text-align: justify;\">Boroughs LK, Deberardinis RJ (2015) Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol 17(4): 351\u2013359. <a href=\"https:\/\/doi.org\/10.1038\/NCB3124\">https:\/\/doi.org\/10.1038\/NCB3124<\/a><\/p>\r\n<p style=\"text-align: justify;\">Chang CH, Lee CY, Lu CC, Tsai FJ, Hsu YM, Tsao JW, Juan YN, Chiu HY, Yang JS, Wang CC (2017) Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt\/mTOR signaling. Int J Oncol 50(3): 873\u2013882. <a href=\"https:\/\/doi.org\/10.3892\/IJO.2017.3866\">https:\/\/doi.org\/10.3892\/IJO.2017.3866<\/a><\/p>\r\n<p style=\"text-align: justify;\">Codenotti S, Zizioli D, Mignani L, Rezzola S, Tabellini G, Parolini S, Giacomini, A, Asperti M, Poli M, Mandracchia D, Vezzoli M, Bernardi S, Russo D, Mitola S, Monti E, Triggiani L, Tomasini D, Gastaldello S, Cassandri M, Fanzani A (2022) Hyperactive Akt1 signaling increases tumor progression and DNA repair in embryonal rhabdomyosarcoma RD line and confers susceptibility to glycolysis and mevalonate pathway inhibitors. Cells 11(18): 2859. <a href=\"https:\/\/doi.org\/10.3390\/CELLS11182859\">https:\/\/doi.org\/10.3390\/CELLS11182859<\/a><\/p>\r\n<p style=\"text-align: justify;\">Cormier KW, Woodgett JR, Beaulieu JM, Eldar-Finkelman H (2017) Recent advances in understanding the cellular roles of GSK-3. F1000Res 6: 167. <a href=\"https:\/\/doi.org\/10.12688\/f1000research.10557.1\">https:\/\/doi.org\/10.12688\/f1000research.10557.1<\/a><\/p>\r\n<p style=\"text-align: justify;\">Dewi FRP, Domoto T, Hazawa M, Kobayashi A, Douwaki T, Minamoto T, Wong RW (2018) Colorectal cancer cells require glycogen synthase kinase-3\u03b2 for sustaining mitosis via translocated promoter region (TPR)-dynein interaction. Oncotarget 9(17): 13337\u201313352. <a href=\"https:\/\/doi.org\/10.18632\/ONCOTARGET.24344\">https:\/\/doi.org\/10.18632\/ONCOTARGET.24344<\/a><\/p>\r\n<p style=\"text-align: justify;\">Domoto T, Uehara M, Bolidong D, Minamoto T (2020) Glycogen synthase kinase 3\u03b2 in cancer biology and treatment. Cells 9(6):1388. <a href=\"https:\/\/doi.org\/10.3390\/CELLS9061388\">https:\/\/doi.org\/10.3390\/CELLS9061388<\/a><\/p>\r\n<p style=\"text-align: justify;\">Foersch S, Sperka T, Lindner C, Taut A, Rudolph KL, Breier G, Boxberger F, Rau TT, Hartmann A, St\u00fcrzl M, Wittkopf N, Haep L, Wirtz S, Neurath MF, Waldner MJ (2015) VEGFR2 signaling prevents colorectal cancer cell senescence to promote tumorigenesis in mice with colitis. Gastroenterology 149(1): 177-189e10. <a href=\"https:\/\/doi.org\/10.1053\/j.gastro.2015.03.016\">https:\/\/doi.org\/10.1053\/j.gastro.2015.03.016<\/a><\/p>\r\n<p style=\"text-align: justify;\">Freund E, Liedtke KR, Miebach L, Wende K, Heidecke A, Kaushik NK, Choi EH, Partecke LI, Bekeschus S (2020) Identification of two kinase inhibitors with synergistic toxicity with low-dose hydrogen peroxide in colorectal cancer cells <em>in vitro<\/em>. Cancers 12(1): 122. <a href=\"https:\/\/doi.org\/10.3390\/CANCERS12010122\">https:\/\/doi.org\/10.3390\/CANCERS12010122<\/a><\/p>\r\n<p style=\"text-align: justify;\">Gong B, Li Z, Xiao W, Li G, Ding S, Meng A, Jia S (2019) Sec14l3 potentiates VEGFR2 signaling to regulate zebrafish vasculogenesis. Nat Comm 10(1): 1606. <a href=\"https:\/\/doi.org\/10.1038\/s41467-019-09604-0\">https:\/\/doi.org\/10.1038\/s41467-019-09604-0<\/a><\/p>\r\n<p style=\"text-align: justify;\">He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Sig Transduct Target Ther 6(1): 425. <a href=\"https:\/\/doi.org\/10.1038\/S41392-021-00828-5\">https:\/\/doi.org\/10.1038\/S41392-021-00828-5<\/a><\/p>\r\n<p style=\"text-align: justify;\">Janani B, Vijayakumar M, Priya K, Kim JH, Prabakaran DS, Shahid M, Al-Ghamdi S, Alsaidan M, Othman BN, Hassan AM, Ramesh T (2022) EGFR-based targeted therapy for colorectal cancer\u2014Promises and challenges. Vaccines 10(4): 499. <a href=\"https:\/\/doi.org\/10.3390\/VACCINES10040499\">https:\/\/doi.org\/10.3390\/VACCINES10040499<\/a><\/p>\r\n<p style=\"text-align: justify;\">Kano A, Iwasaki T, Shindo M (2019) Bongkrekic acid facilitates glycolysis in cultured cells and induces cell death under low glucose conditions. Biochem Biophys Rep 20: 100683. <a href=\"https:\/\/doi.org\/10.1016\/J.BBREP.2019.100683\">https:\/\/doi.org\/10.1016\/J.BBREP.2019.100683<\/a><\/p>\r\n<p style=\"text-align: justify;\">Khalifa SAM, Elias N, Farag MA, Chen L, Saeed A, Hegazy MEF, Moustafa MS, El-Wahed AA, Al-Mousawi SM, Musharraf SG, Chang FR, Iwasaki A, Suenaga K, Alajlani M, G\u00f6ransson U, El-Seedi HR (2019) Marine natural products: A source of novel anticancer drugs. Mar Drugs 17(9): 491. <a href=\"https:\/\/doi.org\/10.3390\/MD17090491\">https:\/\/doi.org\/10.3390\/MD17090491<\/a><\/p>\r\n<p style=\"text-align: justify;\">Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M, White C, Lowe C, Sherba JJ, Hartmanshenn C, O\u2019Neill KM, Balter ML, Fritz ZR, Androulakis IP, Schloss RS, Yarmush ML (2018) The growing role of precision and personalized medicine for cancer treatment. Technology 6(3\u20134): 79\u2013100. <a href=\"https:\/\/doi.org\/10.1142\/S2339547818300020\">https:\/\/doi.org\/10.1142\/S2339547818300020<\/a><\/p>\r\n<p style=\"text-align: justify;\">Liao Z, Li F, Zhang C, Zhu L, Shi Y, Zhao G, Bai X, Hassan S, Liu X, Li T, Xing P, Zhao J, Zhang J, Xing R, Teng S, Yang Y, Chen K, Yang J (2019) Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety. Exp Mol Med 51: 1\u201311. <a href=\"https:\/\/doi.org\/10.1038\/S12276-019-0221-7\">https:\/\/doi.org\/10.1038\/S12276-019-0221-7<\/a><\/p>\r\n<p style=\"text-align: justify;\">Liu K, Ren T, Huang Y, Sun K, Bao X, Wang S, Zheng B, Guo W (2017) Apatinib promotes autophagy and apoptosis through VEGFR2\/STAT3\/BCL-2 signaling in osteosarcoma. Cell Death Dis 8(8): e3015. <a href=\"https:\/\/doi.org\/10.1038\/cddis.2017.422\">https:\/\/doi.org\/10.1038\/cddis.2017.422<\/a><\/p>\r\n<p style=\"text-align: justify;\">Manning BD, Toker A (2017) AKT\/PKB signaling: Navigating the network. Cell 169(3): 381\u2013405. <a href=\"https:\/\/doi.org\/10.1016\/J.CELL.2017.04.001\">https:\/\/doi.org\/10.1016\/J.CELL.2017.04.001<\/a><\/p>\r\n<p style=\"text-align: justify;\">Meng L, Ding L, Yu Y, Li W (2020) JAK3 and TYK2 serve as prognostic biomarkers and are associated with immune infiltration in stomach adenocarcinoma. BioMed Res Int 2020: 7973568. <a href=\"https:\/\/doi.org\/10.1155\/2020\/7973568\">https:\/\/doi.org\/10.1155\/2020\/7973568<\/a><\/p>\r\n<p style=\"text-align: justify;\">Nacion AJD, Park YY, Kim NK (2018) Contemporary management of locally advanced rectal cancer: Resolving issues, controversies and shifting paradigms. Chin J Cancer 30(1): 131\u2013146. <a href=\"https:\/\/doi.org\/10.21147\/J.ISSN.1000-9604.2018.01.14\">https:\/\/doi.org\/10.21147\/J.ISSN.1000-9604.2018.01.14<\/a><\/p>\r\n<p style=\"text-align: justify;\">Ni H, Guo M, Zhang X, Jiang L, Tan S, Yuan J, Cui H. L, Min Y, Zhang J, Schlisio S, Ma C, Liao W, Nister M, Chen C, Li S, Li N (2021) VEGFR2 inhibition hampers breast cancer cell proliferation via enhanced mitochondrial biogenesis. Cancer Biol Med 18(1): 139\u2013154. <a href=\"https:\/\/doi.org\/10.20892\/J.ISSN.2095-3941.2020.0151\">https:\/\/doi.org\/10.20892\/J.ISSN.2095-3941.2020.0151<\/a><\/p>\r\n<p style=\"text-align: justify;\">Oronsky B, Reid T, Larson C, Knox SJ (2020) Locally advanced rectal cancer: The past, present, and future. Sem Oncol 47(1): 85\u201392. <a href=\"https:\/\/doi.org\/10.1053\/J.SEMINONCOL.2020.02.001\">https:\/\/doi.org\/10.1053\/J.SEMINONCOL.2020.02.001<\/a><\/p>\r\n<p style=\"text-align: justify;\">Pabla B, Bissonnette M, Konda VJ (2015) Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention. World J Clin Oncol 6(5): 133\u2013141. <a href=\"https:\/\/doi.org\/10.5306\/WJCO.V6.I5.133\">https:\/\/doi.org\/10.5306\/WJCO.V6.I5.133<\/a><\/p>\r\n<p style=\"text-align: justify;\">Pan X, Xu J, Jia X (2020) Research progress evaluating the function and mechanism of anti-tumor peptides. Cancer Manag Res12: 397\u2013409. <a href=\"https:\/\/doi.org\/10.2147\/CMAR.S232708\">https:\/\/doi.org\/10.2147\/CMAR.S232708<\/a><\/p>\r\n<p style=\"text-align: justify;\">Sciani JM, Emerenciano AK, Cunha da Silva JR, Pimenta DC (2016) Initial peptidomics profiling of Brazilian sea urchins: <em>Arbacia lixula<\/em>, <em>Lytechinus variegatus<\/em>, and <em>Echinometra lucunter<\/em>. J Venom Anim Toxins Incl Trop Dis 22: 17. <a href=\"https:\/\/doi.org\/10.1186\/s40409-016-0071-x\">https:\/\/doi.org\/10.1186\/s40409-016-0071-x<\/a><\/p>\r\n<p style=\"text-align: justify;\">Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin. 73(1): 17\u201348. <a href=\"https:\/\/doi.org\/10.3322\/caac.21763\">https:\/\/doi.org\/10.3322\/caac.21763<\/a><\/p>\r\n<p style=\"text-align: justify;\">Vidri RJ, Fitzgerald TL (2020) GSK-3: An important kinase in colon and pancreatic cancers. Biochim Biophys Acta Mol Cell Res 1867(4): 118626. <a href=\"https:\/\/doi.org\/10.1016\/J.BBAMCR.2019.118626\">https:\/\/doi.org\/10.1016\/J.BBAMCR.2019.118626<\/a><\/p>\r\n<p style=\"text-align: justify;\">Wang X, Bove AM, Simone G, Ma B (2020) Molecular bases of VEGFR-2-mediated physiological function and pathological role. Front Cell and Dev Biol 8: 599281. <a href=\"https:\/\/doi.org\/10.3389\/FCELL.2020.599281\">https:\/\/doi.org\/10.3389\/FCELL.2020.599281<\/a><\/p>\r\n<p style=\"text-align: justify;\">Xiong Z, Graves DB (2017) A novel cupping-assisted plasma treatment for skin disinfection. J Phys D: Appl Phys 50(5): 05LT01. <a href=\"https:\/\/doi.org\/10.1088\/1361-6463\/50\/5\/05LT01\">https:\/\/doi.org\/10.1088\/1361-6463\/50\/5\/05LT01<\/a><\/p>\r\n<p style=\"text-align: justify;\">Zhang N, Tian YN, Zhou LN, Li MZ, Chen HD, Song SS, Huan XJ, Bao X, Bin Zhang A, Miao ZH, He JX (2021) Glycogen synthase kinase 3\u03b2 inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer. Cell Death Dis 12(2): 183. <a href=\"https:\/\/doi.org\/10.1038\/s41419-021-03475-4\">https:\/\/doi.org\/10.1038\/s41419-021-03475-4<\/a><\/p>\r\n<p style=\"text-align: justify;\">Zhong M, Li N, Qiu X, Ye Y, Chen H, Hua J, Yin P, Zhuang G (2020) TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer. Int J Biol Sci 16(2): 272\u2013283. <a href=\"https:\/\/doi.org\/10.7150\/IJBS.37906\">https:\/\/doi.org\/10.7150\/IJBS.37906<\/a><\/p>\r\n<p style=\"text-align: justify;\">Zhou J, Ji Q, Li Q (2021) Resistance to anti-EGFR therapies in metastatic colorectal cancer: Underlying mechanisms and reversal strategies. J Exp Clin Cancer Res 40: 328. <a href=\"https:\/\/doi.org\/10.1186\/S13046-021-02130-2\">https:\/\/doi.org\/10.1186\/S13046-021-02130-2<\/a><\/p>\r\n<p style=\"text-align: justify;\">\u00a9 2025 Journal of Pharmacy &amp; Pharmacognosy Research<\/p>","protected":false},"excerpt":{"rendered":"<p>J. Pharm. Pharmacogn. Res., vol. 13, no. 1, pp. 341-355, Jan-Feb 2025. DOI: https:\/\/doi.org\/10.56499\/jppres24.2085_13.1.341 Original Article Bioinformatic investigation of Lytechinus variegatus coelomic fluid peptides as multiple oncogenic proteins inhibitors of colorectal cancer [Investigaci\u00f3n bioinform\u00e1tica de p\u00e9ptidos del l\u00edquido cel\u00f3mico de Lytechinus variegatus como inhibidores de m\u00faltiples prote\u00ednas oncog\u00e9nicas del c\u00e1ncer colorrectal] Rauza S. Rita1*, Kevin &hellip; <a href=\"https:\/\/jppres.com\/jppres\/lytechinus-variegatus-peptides-and-colorectal-cancer\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Lytechinus variegatus peptides and colorectal cancer<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[],"class_list":["post-18878","post","type-post","status-publish","format-standard","hentry","category-pharmaceutical-science"],"_links":{"self":[{"href":"https:\/\/jppres.com\/jppres\/wp-json\/wp\/v2\/posts\/18878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jppres.com\/jppres\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jppres.com\/jppres\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jppres.com\/jppres\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jppres.com\/jppres\/wp-json\/wp\/v2\/comments?post=18878"}],"version-history":[{"count":0,"href":"https:\/\/jppres.com\/jppres\/wp-json\/wp\/v2\/posts\/18878\/revisions"}],"wp:attachment":[{"href":"https:\/\/jppres.com\/jppres\/wp-json\/wp\/v2\/media?parent=18878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jppres.com\/jppres\/wp-json\/wp\/v2\/categories?post=18878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jppres.com\/jppres\/wp-json\/wp\/v2\/tags?post=18878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}